Disulfiram induces apoptosis in human melanoma cells: A redox-related process

Molecular Cancer Therapeutics

Volumn 1, Issue 3, 2002, Pages 197-204

  Cen, Dazhi ^a   Gonzalez, Rachel I ^a   Buckmeier, Julie A ^a   Kahlon, Ravi S ^a   Tohidian, Nilou B ^a   Meyskens Jr , Frank L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; BUTHIONINE SULFOXIMINE; DISULFIRAM; ENZYME INHIBITOR; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL MEMBRANE POTENTIAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; MELANOCYTE; MELANOMA; METABOLISM; METASTASIS; MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BUTHIONINE SULFOXIMINE; CELL DIVISION; DISULFIRAM; ENZYME INHIBITORS; GLUTATHIONE; MELANOCYTES; MELANOMA; MEMBRANE POTENTIALS; MITOCHONDRIA; NEOPLASM METASTASIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 0036050582     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Davis, W., Jr., Ronai, Z., and Tew, K. D. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J. Pharmacol. Exp. Ther., 296: 1-6, 2001. (Pubitemid 32015053)
2. Janssen-Heininger, Y. M., Poynter, M. E., and Baeuerle, P. A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic. Biol. Med., 28: 1317-1327, 2000. (Pubitemid 30621476)
3. Mates, J. M., and Sanchez-Jimenez, F. M. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell Biol., 32: 157-170, 2000. (Pubitemid 30001819)
4. Kamata, H., and Hirata, H. Redox regulation of cellular signalling. Cell. Signal., 11: 1-14, 1999. (Pubitemid 28546635)
5. Nakamura, H., Nakamura, K., and Yodoi, J. Redox regulation of cellular activation. Annu. Rev. Immunol., 15: 351-369, 1997. (Pubitemid 27169285)
6. Meyskens, F. L., Jr., Chau, H. V., Tohidian, N., and Buckmeier, J. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigm. Cell Res., 10: 184-189, 1997. (Pubitemid 127523207)
7. Meyskens, F. L., Jr., McNulty, S. E., Buckmeier, J. A., Tohidian, N. B., Spillane, T. J., Kahlon, R. S., and Gonzalez, R. I. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic. Biol. Med., in press, 2001.
8. Rodriguez-Vicente, J., Vicente-Ortega, V., and Canteras-Jordana, M. The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. Cancer (Phila.), 82: 495-502, 1998. (Pubitemid 28112988)
9. Fruehauf, J. P, Zonis, S., al-Bassam, M., Kyshtoobayeva, A., Dasgupta, C., Milovanovic, T., Parker, R. J., and Buzaid, A. C. Selective and synergistic activity of L-S, R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase. Pigm. Cell Res., 10: 236-249, 1997. (Pubitemid 127524186)
10. Fruehauf, J. P., Zonis, S., al-Bassam, M., Kyshtoobayeva, A., Dasgupta, C., Milovanovic, T., Parker, R. J., and Buzaid, A. C. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma. Chem.-Biol. Interact. 111: 277-305, 1998. (Pubitemid 28271951)
11. Palomares, T., Bilbao, P., del Olmo, M., Castro, B., Calle, Y., and Alonso-Varona, A. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumor growth of B16 melanoma. Melanoma Res., 9: 233-242, 1999. (Pubitemid 29461140)
12. Thrall, B. D., Raha, G. A., Springer, D. L., and Meadows, G. G. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Pigm. Cell Res., 4: 234-239, 1991.
13. Prezioso, J. A., FitzGerald, G. B., and Wick, M. M. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan. J. Investig. Dermatol., 99: 289-293, 1992.
14. Revesz, L., Edgren, M. R., and Wainson, A. A. Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys., 29: 403-406, 1994. (Pubitemid 24166555)
15. Anderson, C. P., Tsai, J., Chan, W., Park, C. K., Tian, L., Lui, R. M., Forman, H. J., and Reynolds, C. P. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. Eur. J. Cancer, 33: 2016-2019, 1997. (Pubitemid 28123446)
16. Anderson, C. P., Tsai, J. M., Meek, W. E., Liu, R. M., Tang, Y., Forman, H. J., and Reynolds, C. P. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis. Exp. Cell Res., 246: 183-192, 1999. (Pubitemid 29393758)
17. Anderson, C. P., Keshelava, N., Satake, N., Meek, W. H., and Reynolds, C. P. Synergism of buthionine sulfoximine and melphalan cell against neuroblastoma lines derived after disease progression. Med. Pediatr. Oncol., 35: 659-662, 2000.
18. Dai, J., Weinberg, R. S., Waxman, S., and Jing, Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood, 93: 268-277, 1999. (Pubitemid 29019412)
19. Costantini, P., Belzacq, A. S., Vieira, H. L., Larochette, N., de Pablo, M. A., Zamzami, N., Susin, S. A., Brenner, C., and Kroemer, G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene, 19: 307-314, 2000. (Pubitemid 30077228)
20. Burkitt, M. J., Bishop, H. S., Milne, L., Tsang, S. Y., Provan, G. J., Nobel, C. S., Orrenius, S., and Slater, A. F. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch. Biochem. Biophys., 353: 73-84, 1998. (Pubitemid 28373031)
21. Meyskens, F. L., Jr., Buckmeier, J. A., McNulty, S. E., and Tohidian, N. B. Activation of nuclear factor-κ B in human metastatic melanoma cells and the effect of oxidative stress. Clin. Cancer Res., 5: 1197-202, 1999. (Pubitemid 29233238)
22. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods, 184: 39-51, 1995.
23. Benov, L., Sztejnberg, L., and Fridovich, I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med., 25: 826-831, 1998. (Pubitemid 28512535)
24. Ubezio, P., and Civoli, F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic. Biol. Med., 16: 509-516, 1994. (Pubitemid 24105999)
25. Vandeputte, C., Guizon, I., Genestie-Denis, I., Vannier, B., and Lorenzon, G. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol. Toxicol., 10: 415-421, 1994. (Pubitemid 24377319)
26. Balch, C. M., Houghton, A., and Peters, L. Cutaneous melanoma. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles & Practice of Oncology, Chapter 44, pp. 1499-1542. Philadelphia: J. P. Lippincott, 1989.
27. Balch, C. M., Reiretgen, D. S., Kirkwood, J. M., Houghton, A., Peters, C., and Ang, K. K. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles & Practice of Oncology, Chapter 44, pp. 1947-1994 Philadelphia: J. P. Lippincott, 1997.
28. Middleton, M. R., Grob, J. J., Aaronson, N., Fierlbeck, G., Tilgen, W., Seiter, S., Gore, M., Aamdal, S., Cebon, J., Coates, A., Dreno, B., Henz, M., Schadendorf, D., Kapp, A., Weiss, J., Fraass, U., Statkevich, P., Muller, M., and Thatcher, N. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J. Clin. Oncol., 18: 158-166, 2000. (Pubitemid 30036349)
29. Middleton, M. R., Lorigan, P., Owen, J., Ashcroft, L., Lee, S. M., Harper, P., and Thatcher, N. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma. Br. J. Cancer, 82: 1158-1162, 2000. (Pubitemid 30128872)
30. Jungnelius, U., Ringborg, U., Aamdal, S., Mattsson, J., Stierner, U., Ingvar, C., Malmstrom, P., Andersson, R., Karlsson, M., Willman, K., Wist, E., Bjelkengren, G., and Westberg, R. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. Eur. J. Cancer, 34: 1368-1374, 1998. (Pubitemid 28370928)
31. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Seipp, C. A., Einhorn, J. H., White, D. E., and Steinberg, S. M. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon α-2b. J. Clin. Oncol., 17: 968-975, 1999. (Pubitemid 29109330)
32. Chen, S. H., Liu, S. H., Liang, Y. C., Lin, J. K., and Lin-Shiau, S. Y. Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu(2+) complex. Eur. J. Pharmacol., 414: 177-188, 2001. (Pubitemid 32181884)
33. Johansson, B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr. Scand. Suppl., 369: 15-26, 1992.
34. Loeffler, M., and Kroemer, G. The mitochondrion in cell death control: certainties and incognita. Exp. Cell Res., 256: 19-26, 2000. (Pubitemid 30211162)
35. Sato, N., Iwata, S., Nakamura, K., Hori, T., Mori, K., and Yodoi, J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol., 154: 3194-203, 1995.
36. Spyrou, G., and Holmgren, A. Deoxyribonucleoside triphosphate pools and growth of glutathione-depleted 3T6 mouse fibroblasts. Biochem. Biophys. Res. Commun., 220: 42-46, 1996. (Pubitemid 26106796)
37. Mustacich, D., and Powis, G. Thioredoxin reductase. Biochem J., 346: 1-8, 2000. (Pubitemid 30113812)
38. Becker, K., Gromer, S., Schirmer, R. H., and Muller, S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur. J. Biochem., 267: 6118-6125, 2000.
39. Arner, E. S., and Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 267: 6102-6109, 2000.
40. Powis, G., Mustacich, D., and Coon, A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med., 29: 312-322, 2000.
41. Nagendra, S. N., Shetty, K. T., Subhash, M. N., and Guru, S. C. Role of glutathione reductase system in disulfiram conversion to diethyldithiocarbamate. Life Sci., 49: 23-28, 1991.
42. Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., and Debatin, K. M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem., 273: 33942-8, 1998. (Pubitemid 29008858)
43. Costantini, P., Jacotot, E., Decaudin, D., and Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst., 92: 1042-1053, 2000. (Pubitemid 30616479)
44. Kelner, M. J., Bagnell, R., Hale, B., and Alexander, N. M. Inactivation of intracellular copper-zinc superoxide dismutase by copper chelating agents without glutathione depletion and methemoglobin formation. Free Radic. Biol. Med., 6: 355-360, 1989. (Pubitemid 19096925)
45. Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature (Lond.), 407: 390-395, 2000.
46. Shen, H. M., Yang, C. F., Ding, W. X., Liu, J., and Ong, C. N. Superoxide radical-initiated apoptotic signaling pathway in selenite-treated HepG(2) cells: mitochondria serve as the main target. Free Radic. Biol. Med., 30: 9-21, 2001. (Pubitemid 32008084)
47. Kuninaka, S., Ichinose, Y., Koja, K., and Toh, Y. Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br. J. Cancer., 83: 928-934, 2000.
48. Moreno-Manzano, V., Ishikawa, Y., Lucio-Cazana, J., and Kitamura, M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-α-induced apoptosis of rat mesangial cells. J. Biol. Chem., 275: 12684-91, 2000. (Pubitemid 30241419)
49. Kristenson, H. How to get the best out of antabuse. Alcohol Alcohol, 30: 775-783, 1995. (Pubitemid 26017478)